Correlation Between NRx Pharmaceuticals and Effector Therapeutics
Can any of the company-specific risk be diversified away by investing in both NRx Pharmaceuticals and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRx Pharmaceuticals and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NRx Pharmaceuticals and Effector Therapeutics, you can compare the effects of market volatilities on NRx Pharmaceuticals and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRx Pharmaceuticals with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRx Pharmaceuticals and Effector Therapeutics.
Diversification Opportunities for NRx Pharmaceuticals and Effector Therapeutics
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between NRx and Effector is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding NRx Pharmaceuticals and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and NRx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRx Pharmaceuticals are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of NRx Pharmaceuticals i.e., NRx Pharmaceuticals and Effector Therapeutics go up and down completely randomly.
Pair Corralation between NRx Pharmaceuticals and Effector Therapeutics
Assuming the 90 days horizon NRx Pharmaceuticals is expected to generate 5.5 times more return on investment than Effector Therapeutics. However, NRx Pharmaceuticals is 5.5 times more volatile than Effector Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Effector Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 39.00 in NRx Pharmaceuticals on August 29, 2024 and sell it today you would lose (33.71) from holding NRx Pharmaceuticals or give up 86.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.63% |
| Values | Daily Returns |
NRx Pharmaceuticals vs. Effector Therapeutics
Performance |
| Timeline |
| NRx Pharmaceuticals |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
NRx Pharmaceuticals and Effector Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NRx Pharmaceuticals and Effector Therapeutics
The main advantage of trading using opposite NRx Pharmaceuticals and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRx Pharmaceuticals position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.| NRx Pharmaceuticals vs. NRX Pharmaceuticals | NRx Pharmaceuticals vs. Relief Therapeutics Holding | NRx Pharmaceuticals vs. Quantum Si incorporated | NRx Pharmaceuticals vs. Reviva Pharmaceuticals Holdings |
| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |